Summary & Overview
HCPCS G8474: ACE/ARB Therapy Not Prescribed, Documented Reason
HCPCS Level II code G8474 indicates that ACE inhibitor or ARB therapy was intentionally not prescribed and that the clinician documented the reason (clinical contraindication such as allergy, intolerance, pregnancy, ACE-related renal failure, valvular disease, or other medical reasons) or that the patient declined therapy. This code is important nationally because it captures documented deviations from guideline-directed medical therapy for conditions where ACE/ARB agents are commonly considered, supporting quality reporting, continuity of care, and claims clarity.
Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and service implications, common sites of service, and the types of documentation that justify its use. The publication also summarizes typical billing practices, common modifiers observed in claims, and where this code fits within clinical workflows for chronic cardiovascular and renal care.
This summary aims to help billing managers, compliance officers, and clinicians understand the purpose of G8474, the scenarios in which it is applicable, and what documentation elements are typically needed to support its presence on a claim. Data not available in the input is noted where relevant in detailed sections of the publication.
Billing Code Overview
HCPCS Level II code G8474 documents that angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy was not prescribed for reasons documented by the clinician or for patient reasons. The code is used when a clinician records a documented clinical reason (for example, allergy, intolerance, pregnancy, renal failure related to ACE inhibitor use, or valvular disease) or when a patient declines therapy or has other patient-centered reasons.
Service Type: Medication management / therapeutic omission documentation
Typical Site of Service: Outpatient clinic, primary care or specialty ambulatory settings, and other outpatient encounters where chronic cardiovascular or renal medication management is addressed
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of heart failure with reduced ejection fraction (HFrEF) and hypertension presents for routine cardiology follow-up. The clinician reviews current medications and determines that angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy would ordinarily be indicated for afterload reduction and mortality benefit. During the visit the clinician documents a clear reason for not prescribing ACE inhibitor or ARB therapy: the patient has a prior severe angioedema reaction to an ACE inhibitor and an eGFR decline consistent with acute kidney injury after prior ARB exposure. The clinician documents discussion of alternative therapies, the medical rationale for withholding ACE/ARB, and the patient’s agreement.
The clinical workflow: the clinician assesses indications and contraindications, reviews prior allergy/intolerance and laboratory data, documents the specific contraindication (allergy/intolerance, pregnancy, renal failure, valve disease, or patient decline), records the decision in the medical record, and bills the encounter with the appropriate HCPCS code G8474 to indicate ACE inhibitor/ARB therapy was not prescribed for documented reasons. Counseling and alternative medication selection are documented as part of the visit. Typical sites of service include outpatient cardiology clinic, primary care clinic, and hospital outpatient departments where medication management decisions are made.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |